Related Experiment Video

Updated: Mar 7, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

9.0K

MS4A4A and MS4A6A: New targets to enhance microglia protective function in Alzheimer's disease

David V Hansen1, Celeste M Karch2, Drishya Mainali3

  • 1Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.

Neuron
|March 5, 2026
PubMed
Abstract

More Related Videos

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.5K
Obtaining Human Microglia from Adult Human Brain Tissue09:41

Obtaining Human Microglia from Adult Human Brain Tissue

Published on: August 30, 2020

7.9K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K